Benzofurazanyl- and benzofuroxanyl-1,4-dihydropyridines: Synthesis, structure and calcium entry blocker activity

被引:34
作者
Gasco, AM [1 ]
Ermondi, G [1 ]
Fruttero, R [1 ]
Gasco, A [1 ]
机构
[1] UNIV TURIN,DIPARTIMENTO SCI & TECNOL FARMACO,I-10125 TURIN,ITALY
关键词
calcium channel blocker; benzofuroxanyl-1,4-dihydropyridine; benzofurazanyl-1,4-dihydropyridine; benzofuroxan tautomerism; X-ray analysis; FUROXANS;
D O I
10.1016/S0223-5234(96)80001-8
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis, structural characterization and calcium blocking activity of a series of benzofurazanyl-1,4-dihydropyridines (18 and 19) and benzofuroxanyl analogues (20 and 21) are reported. H-1-NMR showed that all the benzofuroxan derivatives exist in solution as tautomeric mixtures. The predominant tautomeric form in solution of the derivative 20 (dimethyl 1,4-dihydro-2,6-dimethyl-4-(4-benzofuroxanyl)-3,5-pyridinedicarboxylate) is also the one preferred in the solid state as shown by X-ray analysis. The conformation in the solid state of the benzofurazanyl analogue is also reported. Calcium entry blocker activity of the dihydropyridine derivatives 18-21 has been evaluated in isolated rabbit basilar artery as relaxation of calcium-induced contractions in high K+-depolarizing solution. All the compounds displayed high potency. The activity of benzofurazan derivatives was not changed by the N-oxidation. The two most active compounds 18 and 20 were as potent as Nifedipine.
引用
收藏
页码:3 / 10
页数:8
相关论文
共 17 条
[1]   CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTER - COMPUTER-BASED SEARCH, RETRIEVAL, ANALYSIS AND DISPLAY OF INFORMATION [J].
ALLEN, FH ;
BELLARD, S ;
BRICE, MD ;
CARTWRIGHT, BA ;
DOUBLEDAY, A ;
HIGGS, H ;
HUMMELINK, T ;
HUMMELINKPETERS, BG ;
KENNARD, O ;
MOTHERWELL, WDS ;
RODGERS, JR ;
WATSON, DG .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1979, 35 (OCT) :2331-2339
[2]   SIR92 - a program for automatic solution of crystal structures by direct methods [J].
ALTOMARE, A ;
CASCARANO, G ;
GIACOVAZZO, G ;
GUAGLIARDI, A ;
BURLA, MC ;
POLIDORI, G ;
CAMALLI, M .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1994, 27 :435-435
[3]  
[Anonymous], 2009, Practical Hemostasis and Thrombosis
[4]   FURAZANS AND FURAZAN OXIDES .1. INTERCONVERSIONS OF ANTHRANILS, BENZOFURAZAN OXIDES, AND INDAZOLES [J].
BALASUBRAHMANYAM, SN ;
RADHAKRISHNA, AS ;
BOULTON, AJ ;
KANWOON, T .
JOURNAL OF ORGANIC CHEMISTRY, 1977, 42 (05) :897-901
[5]   N-OXIDES AND RELATED COMPOUNDS .37. EFFECT OF METHYL AND AZA-SUBSTITUENTS ON TAUTOMERIC EQUILIBRIUM IN BENZOFUROXAN [J].
BOULTON, AJ ;
HALLS, PJ ;
KATRITZKY, AR .
JOURNAL OF THE CHEMICAL SOCIETY B-PHYSICAL ORGANIC, 1970, (04) :636-+
[6]  
DALMONTE D, 1970, ANN CHIM-ROME, V60, P801
[7]   THIOL-MEDIATED GENERATION OF NITRIC-OXIDE ACCOUNTS FOR THE VASODILATOR ACTION OF FUROXANS [J].
FEELISCH, M ;
SCHONAFINGER, K ;
NOACK, E .
BIOCHEMICAL PHARMACOLOGY, 1992, 44 (06) :1149-1157
[8]   A NEW CLASS OF FUROXAN DERIVATIVES AS NO DONORS - MECHANISM OF ACTION AND BIOLOGICAL-ACTIVITY [J].
FERIOLI, R ;
FOLCO, GC ;
FERRETTI, C ;
GASCO, AM ;
MEDANA, C ;
FRUTTERO, R ;
CIVELLI, M ;
GASCO, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (04) :816-820
[9]   POTENTIAL ANTILEUKEMIC AND IMMUNOSUPPRESSIVE DRUGS . PREPARATION AND IN VITRO PHARMACOLOGICAL ACTIVITY OF SOME BENZO-2,1,3-OXADIAZOLES (BENZOFURAZANS) AND THEIR N-OXIDES (BENZOFUROXANS) [J].
GHOSH, PB ;
WHITEHOUSE, MW .
JOURNAL OF MEDICINAL CHEMISTRY, 1968, 11 (02) :305-+
[10]  
Hof R. P., 1988, DRUGS FUTURE, V10, P746